Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker BBIO
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Kumar Haldea Family Irrevocable Tru/T/A DTD 05/18/2019 Director, Officer | BBIO BridgeBio Pharma, Inc. | 30,000 | $2.5M | 10b5-1 | Aug 19, 2026 | Form 4 ↗ 1 day later · 44,980 shares | Form 144 ↗ |
| Aug 18, 2026 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 34,980 | $2.8M | 10b5-1 | Aug 18, 2026 | Form 4 ↗ 2 days later · 44,980 shares | Form 144 ↗ |
| Aug 17, 2026 | Randal Scott Director | BBIO BridgeBio Pharma, Inc. | 21,501 | $1.7M | 10b5-1 | Aug 17, 2026 | — | Form 144 ↗ |
| Jul 9, 2026 | Jennifer Cook Director | BBIO BridgeBio Pharma, Inc. | 148,589 | $13.2M | 10b5-1 | Jul 9, 2026 | Form 4 ↗ 4 days later · 148,589 shares | Form 144 ↗ |
| Jul 9, 2026 | Andrea Ellis Director | BBIO BridgeBio Pharma, Inc. | 17,167 | $1.4M | 10b5-1 | Jul 9, 2026 | Form 4 ↗ 4 days later · 17,167 shares | Form 144 ↗ |
| Jun 24, 2026 | Randal Scott Director | BBIO BridgeBio Pharma, Inc. | 2,196 | $150.7K | 10b5-1 | Jun 24, 2026 | — | Form 144 ↗ |
| Jun 24, 2026 | Jennifer Cook Director | BBIO BridgeBio Pharma, Inc. | 37,167 | $2.6M | 10b5-1 | Jun 24, 2026 | Form 4 ↗ same day · 39,363 shares | Form 144 ↗ |
| Jun 23, 2026 | Jennifer Cook Director | BBIO BridgeBio Pharma, Inc. | 2,196 | $150.6K | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 1 day later · 39,363 shares | Form 144 ↗ |
| Jun 23, 2026 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 2,196 | $150.6K | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 1 day later · 5,004 shares | Form 144 ↗ |
| Jun 22, 2026 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 2,808 | $190.9K | 10b5-1 | Jun 22, 2026 | Form 4 ↗ 2 days later · 5,004 shares | Form 144 ↗ |
| Jun 15, 2026 | Jennifer Cook Director | BBIO BridgeBio Pharma, Inc. | 90,240 | $6.0M | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 90,240 shares | Form 144 ↗ |
| May 21, 2026 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 26,103 | $1.8M | 10b5-1 | May 21, 2026 | Form 4 ↗ 5 days later · 26,103 shares | Form 144 ↗ |
| May 18, 2026 | Thomas Trimarchi Officer | BBIO BridgeBio Pharma, Inc. | 13,651 | $888.4K | 10b5-1 | May 18, 2026 | Form 4 ↗ 1 day later · 13,651 shares | Form 144 ↗ |
| Apr 9, 2026 | Kumar Haldea Revocable Trust U/A DTD 12/19/2018 Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $8.9M | 10b5-1 | Apr 9, 2026 | Form 4 ↗ 4 days later · 80,000 shares | Form 144 ↗ |
| Mar 13, 2026 | Kumar Haldea Family Irrevocable Trust Director, Officer | BBIO BridgeBio Pharma, Inc. | 140,000 | $9.5M | 10b5-1 | Mar 13, 2026 | Form 4 ↗ 3 days later · 80,000 shares | Form 144 ↗ |
| Mar 10, 2026 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 8,671 | $624.3K | 10b5-1 | Mar 10, 2026 | Form 4 ↗ 2 days later · 8,671 shares | Form 144 ↗ |
| Mar 4, 2026 | Andrea Ellis Director | BBIO BridgeBio Pharma, Inc. | 64,921 | $4.2M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 64,921 shares | Form 144 ↗ |
| Feb 27, 2026 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 25,484 | $1.7M | 10b5-1 | Feb 27, 2026 | Form 4 ↗ 4 days later · 25,484 shares | Form 144 ↗ |
| Feb 19, 2026 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 28,053 | $2.1M | 10b5-1 | Feb 19, 2026 | Form 4 ↗ 4 days later · 28,053 shares | Form 144 ↗ |
| Feb 17, 2026 | Randal Scott Director | BBIO BridgeBio Pharma, Inc. | 20,000 | $1.5M | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Feb 17, 2026 | Thomas Trimarchi Officer | BBIO BridgeBio Pharma, Inc. | 13,600 | $1.0M | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 1 day later · 13,600 shares | Form 144 ↗ |
| Jan 8, 2026 | Kumar Haldea Revocable Trust U/A DTD 12/19/2018 Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $8.9M | 10b5-1 | Jan 8, 2026 | Form 4 ↗ 4 days later · 80,000 shares | Form 144 ↗ |
| Jan 8, 2026 | Kumar Haldea Family Irrevocable Trust Director, Officer | BBIO BridgeBio Pharma, Inc. | 100,000 | $7.4M | 10b5-1 | Jan 8, 2026 | Form 4 ↗ 4 days later · 80,000 shares | Form 144 ↗ |
| Dec 15, 2025 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 30,011 | $2.3M | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 1 day later · 30,011 shares | Form 144 ↗ |
| Nov 20, 2025 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 26,156 | $1.7M | 10b5-1 | Nov 20, 2025 | Form 4 ↗ 4 days later · 26,156 shares | Form 144 ↗ |
| Nov 18, 2025 | Andrew W Lo Director | BBIO BridgeBio Pharma, Inc. | 55,000 | $3.6M | — | Nov 18, 2025 | Form 4 ↗ 1 day later · 95,599 shares | Form 144 ↗ |
| Nov 17, 2025 | Andrew W Lo Director | BBIO BridgeBio Pharma, Inc. | 40,599 | $2.7M | — | Nov 17, 2025 | Form 4 ↗ 2 days later · 95,599 shares | Form 144 ↗ |
| Nov 17, 2025 | Randal Scott Director | BBIO BridgeBio Pharma, Inc. | 10,000 | $663.9K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| Nov 17, 2025 | Thomas Trimarchi Officer | BBIO BridgeBio Pharma, Inc. | 16,934 | $1.1M | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 1 day later · 16,934 shares | Form 144 ↗ |
| Nov 12, 2025 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 25,484 | $1.7M | — | Nov 12, 2025 | Form 4 ↗ 2 days later · 25,484 shares | Form 144 ↗ |
| Nov 6, 2025 | Ronald J Daniels Director | BBIO BridgeBio Pharma, Inc. | 61,031 | $3.9M | — | Nov 6, 2025 | Form 4 ↗ 1 day later · 61,031 shares | Form 144 ↗ |
| Oct 29, 2025 | Frank McCormick Director | BBIO BridgeBio Pharma, Inc. | 198,359 | $13.2M | 10b5-1 | Oct 29, 2025 | Form 4 ↗ 2 days later · 198,359 shares | Form 144 ↗ |
| Oct 27, 2025 | Frank McCormick Director | BBIO BridgeBio Pharma, Inc. | 1,641 | $106.7K | 10b5-1 | Oct 27, 2025 | Form 4 ↗ 2 days later · 1,641 shares | Form 144 ↗ |
| Oct 8, 2025 | Kumar Haldea Family Irrevocable Trust Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $6.5M | 10b5-1 | Oct 8, 2025 | Form 4 ↗ 2 days later · 80,000 shares | Form 144 ↗ |
| Oct 8, 2025 | Kumar Haldea Revocable Trust U/A DTD 12/19/2018 Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $6.5M | 10b5-1 | Oct 8, 2025 | Form 4 ↗ 2 days later · 80,000 shares | Form 144 ↗ |
| Sep 5, 2025 | Frank P. McCormick Director | BBIO BridgeBio Pharma, Inc. | 74,000 | $3.9M | — | Sep 5, 2025 | Form 4 ↗ 3 days later · 74,000 shares | Form 144 ↗ |
| Aug 21, 2025 | Thomas Trimarchi Officer | BBIO BridgeBio Pharma, Inc. | 42,237 | $2.1M | — | Aug 21, 2025 | Form 4 ↗ 1 day later · 42,237 shares | Form 144 ↗ |
| Aug 20, 2025 | Neil Kumar Director, Officer | BBIO BridgeBio Pharma, Inc. | 26,156 | $1.3M | 10b5-1 | Aug 20, 2025 | Form 4 ↗ 2 days later · 26,156 shares | Form 144 ↗ |
| Aug 18, 2025 | Thomas Trimarchi Officer | BBIO BridgeBio Pharma, Inc. | 17,353 | $871.7K | 10b5-1 | Aug 18, 2025 | Form 4 ↗ 1 day later · 17,353 shares | Form 144 ↗ |
| Aug 11, 2025 | Charles J Homcy Director | BBIO BridgeBio Pharma, Inc. | 50,000 | $2.4M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 1 day later · 300,000 shares | Form 144 ↗ |
| Aug 8, 2025 | Charles J Homcy Director | BBIO BridgeBio Pharma, Inc. | 250,000 | $11.5M | 10b5-1 | Aug 8, 2025 | Form 4 ↗ 4 days later · 300,000 shares | Form 144 ↗ |
| Aug 5, 2025 | Andrea Ellis Director | BBIO BridgeBio Pharma, Inc. | 17,167 | $841.2K | 10b5-1 | Aug 5, 2025 | Form 4 ↗ 2 days later · 17,167 shares | Form 144 ↗ |
| Jul 1, 2025 | Kumar Haldea Revocabletrust U/A DTD 12/19/2018 Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $5.2M | 10b5-1 | Jul 1, 2025 | Form 4 ↗ 2 days later · 80,000 shares | Form 144 ↗ |
| Jul 1, 2025 | Kumar Haldea Family Irrevocable Tru/T/A DTD 05/18/2019 Director, Officer | BBIO BridgeBio Pharma, Inc. | 120,000 | $5.2M | 10b5-1 | Jul 1, 2025 | Form 4 ↗ 2 days later · 80,000 shares | Form 144 ↗ |
| Jun 26, 2025 | Denis Von Kaeppler IRA Rollover client's wife is a BoD | BBIO BridgeBio Pharma, Inc. | 1,891 | $83.3K | — | Jun 26, 2025 | Form 4 ↗ 4 days later · 4,707 shares | Form 144 ↗ |
| Jun 26, 2025 | Hannah Valantine & Denis Von Kaeppler spouse of bod / bod is joint owner | BBIO BridgeBio Pharma, Inc. | 1,542 | $67.9K | — | Jun 26, 2025 | Form 4 ↗ 4 days later · 4,707 shares | Form 144 ↗ |
| Jun 26, 2025 | Hannah A Valantine & Denis Von Kaeppler JT Ten Officer | BBIO BridgeBio Pharma, Inc. | 876 | $38.6K | — | Jun 26, 2025 | Form 4 ↗ 4 days later · 4,707 shares | Form 144 ↗ |
| Jun 26, 2025 | Ericka Von Kaeppler & Denis Von Kaeppler JT Ten account owners are spouse and daughter… | BBIO BridgeBio Pharma, Inc. | 398 | $17.6K | — | Jun 26, 2025 | Form 4 ↗ 4 days later · 4,707 shares | Form 144 ↗ |
| Jun 24, 2025 | Frank McCormick Officer | BBIO BridgeBio Pharma, Inc. | 100,000 | $4.4M | 10b5-1 | Jun 24, 2025 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| Jun 10, 2025 | Hannah A Valantine Director | BBIO BridgeBio Pharma, Inc. | 4,292 | $171.7K | 10b5-1 | Jun 10, 2025 | Form 4 ↗ 1 day later · 4,292 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:19 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances